Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TP53 |
| Variant | Y220N |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | TP53 Y220N lies within the DNA-binding domain of the Tp53 protein (PMID: 22713868). Y220N is predicted to result in decreased Tp53 stability based on computer modeling (PMID: 31990523), but has not been biochemically characterized and therefore, its effect on Tp53 protein function is unknown (PubMed, May 2026). |
| Associated Drug Resistance | |
| Category Variants Paths |
TP53 mutant TP53 exon6 TP53 Y220N |
| Transcript | NM_000546.6 |
| gDNA | chr17:g.7674873A>T |
| cDNA | c.658T>A |
| Protein | p.Y220N |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001126113.3 | chr17:g.7674873A>T | c.658T>A | p.Y220N | RefSeq | GRCh38/hg38 |
| NM_001126112.3 | chr17:g.7674873A>T | c.658T>A | p.Y220N | RefSeq | GRCh38/hg38 |
| NM_001407268.1 | chr17:g.7674873A>T | c.658T>A | p.Y220N | RefSeq | GRCh38/hg38 |
| NM_000546.6 | chr17:g.7674873A>T | c.658T>A | p.Y220N | RefSeq | GRCh38/hg38 |
| NM_001407262.1 | chr17:g.7674873A>T | c.658T>A | p.Y220N | RefSeq | GRCh38/hg38 |
| NM_001407266.1 | chr17:g.7674873A>T | c.658T>A | p.Y220N | RefSeq | GRCh38/hg38 |
| NM_001407270.1 | chr17:g.7674873A>T | c.658T>A | p.Y220N | RefSeq | GRCh38/hg38 |
| NM_001126114.3 | chr17:g.7674873A>T | c.658T>A | p.Y220N | RefSeq | GRCh38/hg38 |
| NM_001407264.1 | chr17:g.7674873A>T | c.658T>A | p.Y220N | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| TP53 Y220N | Advanced Solid Tumor | no benefit | Rezatapopt | Preclinical - Cell culture | Actionable | In a preclinical study, Rezatapopt (PC14586) partially stabilized Tp53 protein and marginally inhibited proliferation, but did not inhibit viability and colony formation, and did not induce apoptosis in cells expressing TP53 Y220N in culture (PMID: 41748563). | 41748563 |